Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950168-02-000017
Filing Date
2002-01-11
Accepted
2002-01-11 00:00:00
Documents
1
Period of Report
2002-03-07

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY NOTICE & PROXY STATEMENT dpre14a.txt PRE 14A 102934
  Complete submission text file 0000950168-02-000017.txt   104581
Mailing Address PO BOX 14287 PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 000-27410 | Film No.: 2507564
SIC: 2834 Pharmaceutical Preparations